secwatch.observer — SEC 8-K summary
======================================

Issuer:     CORVEL CORP (CRVL)
CIK:        0000874866
Form:       8-K
Filed at:   2021-08-03T23:59:59+00:00
Accession:  0001564590-21-039906
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CorVel Q1 FY2022 EPS $0.92 vs $0.46 YoY; revenue $153M up 18%
-------------------------------------------------------------

- EPS $0.92 vs $0.46 in prior-year quarter; net income doubled YoY.
- Revenue $153M, up from $130M a year ago (+18%).
- Cash balance $139M, up $45M from June 30, 2020.
- Company cites resumption of medical procedures, higher claims and bill volumes, and demand for managed care driving growth.
- Building telehealth operations and analytic tools to improve outcomes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/874866/000156459021039906/0001564590-21-039906-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/874866/000156459021039906/crvl-8k_20210803.htm
  HTML page:      https://secwatch.observer/filing/0001564590-21-039906

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer